Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2019 08:10 ET | Source: Exagen, Inc.

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
November 22, 2019 08:25 ET | Source: Exagen, Inc.

Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management

SAN DIEGO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
November 21, 2019 08:25 ET | Source: Exagen, Inc.

Exagen Inc. Announces $26.2 Million Debt Refinancing

SAN DIEGO, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
November 20, 2019 05:15 ET | Source: Exagen, Inc.

Exagen Inc. to Participate in the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
October 28, 2019 08:15 ET | Source: Exagen, Inc.

Exagen Featured in Nine Scientific Presentations at 2019 ACR/ARHP Annual Meeting in Atlanta

SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
October 21, 2019 08:15 ET | Source: Exagen, Inc.

Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America

SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
October 15, 2019 08:15 ET | Source: Exagen, Inc.

Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing

SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
August 19, 2019 08:57 ET | Source: Exagen Inc.

Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research

San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
April 24, 2019 09:55 ET | Source: Exagen Diagnostics, Inc.

New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
March 26, 2019 08:45 ET | Source: Exagen Diagnostics, Inc.

JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors

San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...

Next Page keyboard_arrow_right